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The interaction between the Shiga toxin B-subunit (STxB) and its globotriao-
sylceramide receptor (Gb3) has a high potential for being exploited for tar-
geted cancer therapy. The primary goal of this study was to evaluate the
capacity of STxB to carry small molecules and proteins as cargo into cells.
For this purpose, an assay was designed to provide real-time information
about the StxB–Gb3 interaction as well as the dynamics and mechanism of
the internalization process. The assay revealed the ability to distinguish the
process of binding to the cell surface from internalization and presented the
importance of receptor and STxB clustering for internalization. The overall
setup demonstrated that the binding mechanism is complex, and the concept
of affinity is difficult to apply. Hence, time-resolved methods, providing
detailed information about the interaction of STxB with cells, are critical for
the optimization of intracellular delivery.
Keywords: binding kinetics; cancer; cell surface receptor; real-time cell-
binding assays; receptor internalization; Shiga toxin
One of the major challenges of cancer therapy is selec-
tivity. Compounds that target cancer cells with high
specificity minimize the risk of side effects in healthy
tissue, thus potentially improving the quality of life for
patients [1]. Discovering vectors that bind to cell sur-
face molecules that are specific for, or overproduced
by, cancer cells enables the design of therapies that
target cancer with higher specificity [2]. Targeting
strategies where a chemotherapeutic agent is conju-
gated to a carrier, such as a monoclonal antibody,
have been described and are being further explored for
improving drug efficiency. This strategy of combining
cytotoxic drugs with antibodies, termed antibody-drug
conjugates, has already resulted in approved medica-
tions, for example, brentuximab, vedotin, and ado-
trastuzumab emtansine [3]. However, resistance to
Abbreviations
eGFP, enhanced green fluorescent protein; FITC, fluorescein isothiocyanate; Gb3, globotriaosylceramide; RT-CBA, real-time cell-binding
assays; STxB, Shiga toxin subunit B.
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these drugs has been reported, caused by mechanisms
such as impaired lysosomal function or antigen-related
resistance [4].
To evade resistance, modified treatment strategies
for delivery of conjugates into cells are desired. One
alternative is presented by Shiga toxin. This toxin is
produced by intestinal pathogenic bacteria such as
Shigella dysenteriae and shigatoxigenic serotypes of
Escherichia coli (STEC). It is composed of two sub-
units (A and B) with distinct roles. The nontoxic sub-
unit B is a pentameric protein that binds the toxic
subunit A and is then instrumental in a mechanism
that internalizes the complex into cells upon which
subunit A is released. Since Shiga toxin is an intestinal
virulence factor with high stability in different physio-
logical environments, the toxin has received consider-
able attention [5]. The reason why Shiga toxin can
internalize in cells is because the B-subunit (STxB)
specifically binds to its natural globotriaosylceramide
receptor (Gb3, also known as CD77 and ceramide tri-
hexoside) on mammalian cells [6]. Interestingly, Gb3 is
not a protein, but a globoside consisting of galactose
linked to lactosylceramide. Three trisaccharide mole-
cules are bound to each B-subunit monomer, orienting
the toxin on the surface and the multivalent interac-
tions contribute to a high functional affinity or avidity.
Moreover, this initiates a membrane reorganization,
and induces curvature and toxin clustering, the first
step in the formation of tubular endocytic pits [7].
Thus, once STxB binds to Gb3 at the cell surface, it is
rapidly internalized by endocytosis, reaching the early
and recycling endosomes [8]. STxB can thereafter
escape the late endocytic pathway through an intracel-
lular trafficking termed the retrograde route, thus
avoiding the extreme environment of lysosomes [9].
The internalization mechanism of STxB has been
extensively studied, and it has been observed that
STxB, once bound to the lipid bilayer, has the capacity
to form membrane invaginations by glycolipid receptor
clustering. It has also been reported that STxB binds
to Gb3 by both the dependent clathrin machinery and
independent clathrin machinery [10].
Some human cancers, such as lymphomas and col-
orectal carcinomas, have high levels of Gb3 exposed
on their outer cell surface. Cancer cells have up to 108
binding sites for STxB [11], whereas there are typically
at most 106–107 binding sites for antibodies per target
cell, as, for example, shown for the EGFR-binding
antibody cetuximab [12]. STxB may therefore be an
effective carrier for delivering small peptides or mole-
cules into cancer cells, and STxB conjugated with dif-
ferent drugs, such as auristatin derivatives and SN-38,
has consequently been explored [11,13]. Different
strategies for conjugating drugs with the STxB subunit
have been applied, for example, using cysteine cou-
pling or linkers that allow drug-release upon reaching
a reducing environment [14].
At the molecular level, different aspects of the inter-
action between STxB and Gb3 have been investigated.
It includes studying the interaction between the mole-
cules by SPR-biosensor assays [15,16], assessing the
ability of STxB to form membrane invagination by
using giant unilamellar vesicles or investigating intra-
cellular events through microscopy [17]. However,
defining the interaction characteristics by biophysical
methods requires artificial approximations in nonphysi-
ological conditions: in particular, does not account for
the importance of specific moieties in the glycolipids
and the toxin for the interactions (i.e., not employing a
lipid bilayer system). Such simplified systems may not
adequately reflect the actual events occurring on the
cell membrane or the stimuli of biological processes
[18]. Experiments have also been performed under con-
ditions that mimic cell membrane environments, result-
ing in different apparent affinities ranging from high
(521 nM) to low (8 nM) nanomolar range [16,17]. For
interactions on cells, it has been observed that the
apparent affinity ranges between 4.7 and 80 nM,
depending on the cell type [19,20]. The complexity of
the cell membrane and the different species of the Gb3
receptor on different cell lines imply that it is a system
that is difficult to mimic with assays that employ recep-
tors outside their cellular environment.
This complexity might partly be caused by the clus-
tering of the plasma membrane receptors upon ligand
binding. For example, it has been described that
unstimulated lipid raft domains are usually small (2–
10 nm), extremely dynamic and ephemeral (1 ns–1 s).
In contrast, upon external stimuli, raft-associated
receptors cluster together to form stable, larger
domains in the size range of 10–20 nm that possess a
longer lifetime [21]. Glycolipid receptor clustering
upon STxB binding to a lipid bilayer is an example of
this phenomenon. The reason may be the interaction
between STxB and up to 15 Gb3 molecules, leading to
a contraction of lipids underneath the protein, and a
local thickening of the membrane. Once STxB binds to
the outer membrane leaflet, clustered ligand–receptor
mass exerts a local stress on the toxin-binding site
which translates into negative membrane curvature.
This, in turn, leads to an increased surface area that
facilitates additional ligand binding. As a result of this
local compaction of lipids, more ligand molecules bind
and boost the membrane deformation, thus leading to
tubule formation once a critical concentration of
ligand–receptor clusters is achieved [22].
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In this study, our primary goal was to evaluate the
capacity of STxB to carry big and small cargo mole-
cules into cells. By conjugating STxB with a green flu-
orescent protein (eGFP) or with fluorescein (FITC),
the binding and delivery capacity as function of tem-
perature, time, and concentration could be estimated
for the two types of cargo. To obtain detailed informa-
tion on the apparent kinetics and apparent affinity of
the STxB–Gb3 interaction, as well as the internaliza-
tion processes, we employed a real-time cell-binding
assay (RT-CBA) [23]. Discrepancies between the STxB
binding and internalization rates obtained with RT-
CBA and reported results from end point measure-
ments [24] were observed. RT-CBA was therefore used
to further explore the interaction and internalization
mechanisms of the STxB constructs. Additionally,
proximity assays between STxB fluorescent and
quenched labeled forms were performed to evaluate
the impact of time on the STxB binding, proximity,
and compaction to Gb3 receptors.
Materials and methods
Cloning, proteins expression, and purification
A pET46 expression plasmid containing the gene encoding
full-length subunit B of Shiga toxin (STxB) type I with an
N-terminal hexahistidine tag was provided by Helmholtz
Zentrum, Munich. A second construct (STxB–eGFP) was
made by using the STxB containing plasmid as a template
for PCR amplification of the gene. Thereafter, the eGFP
gene was fused to the C-terminal of STxB through a GSGS
linker via PCR. The amplified product was later inserted
into a pETSumo expression vector (HMGU library)
between BsaI and NotI restriction sites.
STxB and STxB–eGFP with His-tags were expressed in
E. coli BL21 (DE3) cells grown in LB medium supple-
mented with 100 µgmL1 ampicillin (STxB) or 50 µgmL1
kanamycin (STxB–eGFP). The cells were grown at 37 °C
until the optical density (OD600) of the culture reached 0.7.
The temperature was then lowered to 20 °C, and isopropyl
b-D-1-thiogalactopyranoside was added to a final concen-
tration of 1 mM. The cells were allowed to grow overnight
where after they were harvested by centrifugation for
15 min at 6000 g, resuspended in lysis buffer (PBS pH 8.0;
Medicago AB, Uppsala, Sweden) supplemented with pro-
tease inhibitors—(cOmpleteTM EDTA-free; Roche, Basel,
Switzerland), 10 µgmL1 DNAse (bovine pancreas, grade
II; Sigma-Aldrich, St. Louis, MO, USA), 500 µgmL1
lysozyme (chicken egg white, grade VI; Sigma-Aldrich),
4 mM MgCl2 (Sigma-Aldrich), and 5 mM imidazole (Sigma-
Aldrich). The STxB expressing cells were lysed by sonica-
tion, while the STxB–eGFP expressing cells were lysed by
liquid homogenization with the use of a French press
(since, in this case, seem to avoid protein precipitation in
inclusion bodies). The lysates were clarified by centrifuga-
tion at 20 000 g for 1 h, and the supernatants were applied
to a Ni-NTA agarose resin (Qiagen, Hilden, Germany) pre-
equilibrated with lysis buffer. The hexahistidine-tagged pro-
teins were eluted from the Ni-NTA agarose resin using an
elution buffer (200 mM imidazole in lysis buffer). For
STxB, an additional purification step was performed via
size exclusion chromatography (SEC) using a Superdex 75
Hiload 16/60 column (GE Healthcare, Chicago, IL, USA).
The protein was eluted in PBS (pH 7.4) and incubated
overnight with SUMO hydrolase (dtUD1), in order to cut
the tag from the STxB–eGFP-SUMO fusion protein.
STxB–eGFP was then purified via Ni-NTA affinity chro-
matography and SEC, using a Superdex 200 10/300 GL
column (GE Healthcare) and PBS as carrier buffer. Both
proteins were concentrated via ultrafiltration (cutoff
30 kDa, Amicon Ultra-15; Merck Milipore, Burlington,
MA, USA). Aliquots of the proteins were then flash-frozen
in liquid nitrogen and stored at 80 °C. The purity of the
protein was estimated by SDS–PAGE and the concentra-
tion by NanoDrop ND-1000 Spectrophotometer (Marshall
Scientific, Hampton, NH, USA). A stock sample of the
STxB constructs was taken from 80 °C storage and
thawed directly before analysis. The homogeneity of the
samples of the STxB constructs was confirmed by dynamic
light scattering analysis using Zetasizer Ultra (Malvern
Panalytical, Malvern, UK).
STxB labeling
The His-tagged STxB protein was labeled with either fluo-
rescein isothiocyanate (F3651; Merck Life Sciences, Darm-
stadt, Germany) or with the quencher ATTO540Q (AD
540Q-31; Atto-Tech, Amherst, NY, USA) via primary ami-
nes, that is, lysines. This was performed as previously
described [25]. The labeled protein was then purified
through a NAP-5 column (GE Healthcare) in PBS pH 7.4
for the removal of unbound fluorophore.
Differential scanning fluorimetry (nanoDSF)
The thermal stability of STxB and FITC-labeled STxB was
determined by differential scanning fluorimetry monitoring
intrinsic fluorescence (nanoDSF) using a Tycho NT6 instru-
ment (Nanotemper Technologies, Munich, Germany). Two
capillaries were filled with samples of unlabeled STxB
(0.1 mgmL1 protein in PBS pH 7.4), and STxB amino cou-
pled with FITC (0.1 mgmL1 protein in PBS pH 7.4). Intrin-
sic fluorescence was monitored at 330 and 350 nm
(tryptophan and tyrosine emission wavelengths, respectively)
during a thermal ramp. The inflection temperature (Ti) was
calculated as the inflection point in the shift of intrinsic fluo-
rescence. The same experiment was performed in duplicate
with samples that were kept at 4 °C for a week after thawing.
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Culture and seeding of cells
Ramos (ATCC CRL-1596TM), Daudi (ATCC CCL-
213TM), and K562 cells (ATCC CCL-243TM) were cultured
in RPMI-1640 (cat. no. F1215; Merck Sharp & Dohme
Ltd., Hoddesdon, UK). The human HT-29 colon carci-
noma cell line was cultured in McCoy’s cell culture medium
(cat. no. 16600082; Invitrogen, Carlsbad, CA, USA). Both
types of cell culture media were supplemented with 10%
fetal bovine serum (cat. no. F6765; Sigma-Aldrich; Merck
KGaA, Darmstadt, Germany), 2 mM L-glutamine (cat. no.
K0283; Merck Sharp & Dohme Ltd.), 100 IU penicillin,
and 100 µgmL1 streptomycin (cat. no. A2213; Merck
Sharp & Dohme Ltd.). For Daudi cells, 1% sodium pyru-
vate (Sigma-Aldrich) was also added.
For RT-CBA (see below) with Daudi, Ramos, and
K562, the suspension cells were seeded and tethered on
Petri dishes as described by Bondza et al. [26]. For easy
comparison between the binding of STxB–FITC and
STxB–eGFP to living cells, both ligands were measured
simultaneously using LigandTracer MultiDish 2 9 2 (Cat.
No. 1-4-201; Ridgeview Instruments AB, Uppsala, Swe-
den). MultiDish 2 9 2 was coated with Polydopamine for
HT-29 cells since improvement of cell attachment was
needed. In all measurements, a cell-free area of the com-
partment was used as a reference. Cell seeding to the Mul-
tiDish was performed according to the manufacturer’s
instructions.
Real-time cell-binding assays
The interactions of FITC-labeled STxB and STxB–eGFP
with HT-29, Daudi, and Ramos cells were measured in a
RT-CBA with LigandTracer Green (Ridgeview Instru-
ments AB), using a blue (488nm)  green (535 nm) detec-
tor. Measurements were conducted in cell culture medium
(see above) and started with a short baseline measurement
in the absence of labeled protein. STxB–FITC or STxB–
eGFP was then added to the medium to give the specified
final concentration. Association phase data were subse-
quently recorded for a defined time (typically 3–6 h). In
some cases, more STxB was added to get data for multi-
ple concentrations in series. The solution was then
replaced with fresh medium to monitor the dissociation
of STxB from the cells. Experiments at different tempera-
tures were performed by placing the complete instrument
in a temperature-controlled cabinet [27]. For understand-
ing the impact of time on the binding mechanism of the
STxB constructs, STxB–eGFP or STxB–FITC was added
stepwise at shorter (0.5 + 1 h) or longer (3 + 3 h) incuba-
tion times. For the proximity assays, a defined concentra-
tion of STxB–eGFP or STxB–FITC was incubated until a
clear signal increase was obtained followed by the addi-
tion of STxB labeled with the quencher molecule
ATTO540Q. If the two STxB constructs bound in prox-
imity on the cell surface, a decrease in the slope of the
binding curve was expected. To exclude competition
between the STxB constructs as a cause for signal
decrease, control experiments with unlabeled STxB were
performed.
Data analysis
RT-CBA traces produced with LigandTracer Green were
analyzed using the evaluation software TRACEDRAWER 1.8
(Ridgeview Instruments AB). Data were normalized to
allow a simple comparison of binding curves. In Figs 4 and
7, the signal was normalized by setting to 100% at the end
of the second incubation phase for better comparison
between different temperatures and incubation times. In
Fig. 6, the signal was normalized after 3 h of STxB incuba-
tion to enable comparisons between the association and
dissociation phases at different temperatures. For estimat-
ing the internalization rates from Fig. 8A, data from con-
centration series of STxB–eGFP (3–270 nM) were
normalized at 30 min from the association phase. Percent-
age of internalized STxB–eGFP per hour relative to the
number of surface-bound STxB–eGFP was obtained by
relating the slope of the linear increase (from the time
points from 2 to 3 h of incubation) to the surface-bound
STxB–eGFP at equilibrium conditions (signal plateau) at
lower concentrations (3 nM). For the proximity experiments
(Fig. 9), to clearly visualize the quenching effect, data were
normalized by setting the baseline levels to zero and the
time point when it was either STxB-ATTO540Q or unla-
beled STxB was added to 100%.
Detailed kinetic information for interactions can be esti-
mated from binding curves in the form of association and
dissociation rates, theoretically defined as kinetic parame-
ters (ka and kd, respectively). For a Langmuir 1 : 1 binding
model where a reversible interaction between two species




¼ ka  ½L  ½T  kd  ½LT:
In real-time techniques for measuring interactions, it is
assumed that the number of targets ([T]) is constant over
time and that depletion of the ligand (L) is negligible. If
these assumptions are met, the measured signal (B) is pro-
portional to the number of complexes (LT) formed. Thus,
the equation above can be written as follows:
d½B
dt
¼ ka  ½L  ðBmax  BÞ  kd  B;
Bmax represents the signal when receptors are saturated
with ligand (L).
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Confocal microscopy
HT-29 and Daudi cells were immobilized on nontreated µ-
slides (80821; Ibidi, Martinsried, Germany) for immunoflu-
orescence studies. Cells were incubated for 3 h with STxB–
FITC and STxB–eGFP to a final concentration of 30 nM
(Fig. 5) or 90 nM (Fig. 8D, STxB–eGFP). For cell mem-
brane detection, cells were stained with the dye CellMaskTM
Deep Red Plasma Membrane Stain (C10046; Invitrogen)
according to the manufacturer’s protocols. Slides were cap-
tured with a Zeiss LSM 700 confocal microscope (Zeiss,
Oberkochen, Germany). Images were processed using IM-
AGEJ software (U. S. National Institutes of Health,
Bethesda, MD, USA).
Results
Analysis of thermal stability of STxB by nanoDSF
To evaluate how STxB was affected by FITC-labeling,
a thermal shift analysis monitoring the intrinsic fluo-
rescence at 330 and 350 nm from 35 °C to 95 °C was
performed. The absorbance ratio was plotted as a
derivative to get the inflection temperatures for the dif-
ferent measurements (Fig. 1). A 6.4 °C difference in
the inflection temperature between unlabeled STxB
and the labeled form STxB–FITC (78.7 °C and
72.3 °C, respectively) indicates that the stability of
STxB is negatively reduced by the labeling, but a steep
denaturation curve indicates that the protein is still
folded. The same result was observed after storage for
a week at 4 °C.
Evaluation of STxB-specific interactions with
Gb3-positive cell lines
The ability of STxB to bind to cells and internalize
while fused to the small molecule fluorescein or the
protein eGFP was explored. Daudi, Ramos, and HT-
29 cells were chosen since they have high levels of Gb3
on their surface. The K562 cell line was used as nega-
tive control as it does not contain extracellular Gb3.
First, STxB–FITC was used to confirm that STxB
only interacts with Daudi cells with Gb3 on the extra-
cellular surface (Fig. 2). After seeding and tethering
cells onto a Petri dish, STxB–FITC was added to a
final concentration of 30 nM and the association was
monitored for almost five hours. This was followed by
a dissociation rate measurement using fresh medium
without STxB–FITC (the small shifts in signal at the
start and end of the association phase are typical from
real-time methods associated, in this case, with fluores-
cent liquid and not from actual interaction events).
STxB was found to interact reversibly with the cul-
tured Daudi cells (Fig. 2, black), but not with K562
cells (Fig. 2, gray). Both the association and dissocia-
tion phases had an initial ‘burst’, followed by a linear
phase, indicating that there are (at least) two events
taking place, with a first rapid event being followed by
a slower more continuous process. Control experi-
ments with reactive uncoupled FITC or a fusion eGFP
(fusion protein with the same GSGS linker strategy)
were also conducted and did not show unspecific bind-
ing to target cells (data not shown).
Secondly, the interaction was confirmed with STxB–
eGFP (90 nM) and HT-29 cells (Fig. 3) while prolong-
ing the incubation time to obtain more information on
the slower continuous process observed for STxB–
FITC. The biphasic behavior was also observed for
STxB–eGFP, with the linear phase being constant for
more than 12 h.
The characteristics of STxB–FITC and STxB–eGFP
interactions with Gb3 expressing cell lines were further
explored. Two different concentrations and two incu-
bation times were used in order to elucidate the mech-
anistic basis for the biphasic behavior seen during
both the association and dissociation part of the mea-
surement (Fig. 4).
When the STxB variants were incubated with
Ramos cells for short times (0.5 + 1 h), only the ini-
tial nonlinear phase was seen during the association
phase (Fig. 4A,B), similar to a simple 1 : 1 interaction
with one reversible step. However, signs of a more
Fig. 1. nanoDSF analysis of STxB and STxB–FITC. First derivative
of the ratio of the intrinsic fluorescence detected at 350 and
330 nm of STxB–FITC (gray) and STxB unlabeled (black) both at a
final concentration of 0.1 mgmL1, as a function of temperature.
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complex interaction were observed in the dissociation
phase, with an initial rapid and considerable release
of labeled STxB, followed by a stable signal that did
not show any tendency to return to baseline. In con-
trast, when the STxB variants were incubated for
longer times (3 + 3 h), the association rate was bipha-
sic, with an initial rapid signal increase, followed by a
slower linear increase (Fig. 4C,D). Moreover, the ini-
tial rapid release of labeled protein in the dissociation
was less pronounced when incubation times were
longer. The same behavior was seen for both variants
of STxB, but with differences in the kinetics and mag-
nitude of the effects. The interaction data suggest that
for both STxB variants, two processes occur: (a) a
direct interaction between STxB and Gb3 receptors,
and (b) an internalization of STxB. Furthermore, the
amount of internalized STxB appears to depend on
the incubation time. In addition to STxB internaliza-
tion, yet another process involving production or
recycling of Gb3 by metabolically active cells may
increase the concentration of Gb3 on the surface if
the time for the experiment is long relative to the rate
of synthesis/recycling.
Confirming internalization of STxB
To investigate whether the STxB variants were in fact
internalized, as suggested by the experiments above
(Fig. 4), an orthogonal live-imaging confocal experi-
ment was performed. STxB–eGFP and STxB–FITC
were incubated with Daudi cells for 3 h, whereafter a
Z stack from the confocal was imaged (Fig. 5). Both
STxB variants were indeed internalized after 3 h, and
signs of tubular membrane formations could be
observed. It was also observed that STxB constructs
were not evenly distributed on the cell membrane and
a higher level of STxB appears to be in clusters on the
cell surface and in tubular formations.
Effect of cell metabolism on STxB interactions
with cells
To understand how the metabolic status of cells influ-
ences their interaction with STxB, RT-CBAs were per-
formed at different temperatures (Fig. 6). A first series
of experiments was performed on Daudi cells
(Fig. 6A–C). When incubating with 30 nM STxB–
Fig. 2. Analysis of STxB–FITC interactions
with Gb3-positive and Gb3-negative cells.
RT-CBA traces for 30 nM STxB–FITC
incubated with Daudi (black) and K562
(gray) cells at room temperature.
Association was monitored for 5 h after
baseline acquisition, and the dissociation
rate was studied after replacing the
medium with fresh medium without
STxB–FITC (t = 5.6 h). The small shifts in
signal at the start and end of the
association phase are due to adding/
removing a fluorescent compound and not
actual interaction events.
Fig. 3. Analysis of STxB–eGFP
interactions with HT29 cells. RT-CBA
traces of 90 nM of STxB–eGFP incubated
for more than 12 h at room temperature.
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eGFP for 3 h at low temperature (8 °C), the interac-
tion seemed to reach equilibrium (Fig. 6A, black).
When fresh medium was added to follow dissociation,
the decrease was linear. The measured interaction
curve fitted a 1-step, 1 : 1 interaction model very well,
with a resulting apparent affinity (KD) of 1.92 nM
(with ka = 2.6 9 10
3
M
1s1 and kd = 5.1 9 106s1).
However, time turned out to be a crucial parameter
for the kinetics of the STxB interaction. By increasing
the incubation time to more than 3 h, a second phase
with an almost linear signal increase was observed dur-
ing the association (Fig. 6A, gray).
To explore the effect of cell metabolism on the
kinetics and to determine whether the second phase of
the rate is due to a biological event, the experiments
were repeated at 37 °C (Fig. 6C). The initial signal
burst in the association phase was faster and leveled
off within just one hour, and the linear phase was
more distinct and with a higher slope compared to the
experiments at 8 °C.
The first part of the association curve is interpreted
as the actual binding of STxB–eGFP to the cells, with
a signal that increased rapidly until a pseudo/
quasiequilibrium-binding level was reached, at a rate
that increased with temperature (Fig. 6B,C). The sub-
sequent continuous linear signal increase is not consis-
tent with any process where receptors become
saturated. This may be explained by internalization,
supported by the observation that the dissociation at
37 °C showed a relatively rapid signal decrease during
the first hour, followed by a stable signal that did not
return to baseline. It would suggest that roughly 80%
of the fluorescence remains within Daudi cells
(Fig. 6C).
The interaction between STxB–eGFP and HT-29
cells showed a similar behavior as observed with
Daudi cells (Fig. 6D–F). Again, at 8 °C, prolonging
the incubation time for longer than 3 h showed that
the interaction was not adequately described by a 1 : 1
binding process (Fig. 6D). However, when considering
the data from the association and dissociation in
Fig. 6D (black curve), a similar affinity value was
obtained (KD = 1.68 nM), but the binding and dissoci-
ation of STxB–eGFP with HT-29 cells was slightly fas-
ter compared to the same interaction on Daudi cells
(ka = 1.11 9 10
4
M
1s1 and kd = 1.87 9 105s1).
When the temperature was increased, a faster interac-
tion was seen (Fig. 6E,F).
The effect of increasing the STxB concentration
was also tested at different temperatures, in order to
distinguish the binding signal from signal changes
caused by secondary processes related to internaliza-
tion or metabolic processes in the cell (Fig. 7). When
STxB–FITC or STxB–eGFP was incubated at an
Fig. 4. Analysis of the effect of STxB–FITC and STxB–eGFP concentrations and incubation times on cell interactions. RT-CBA with 30 and
90 nM STxB–FITC (A, C) or STxB–eGFP (B, D) incubated with Ramos cells for either 0.5 + 1 h (A, B) or 3 + 3 h (C, D).
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initial 30 nM concentration, the signal approached an
equilibrium (disregarding the second linear phase
that was evident in some cases). When a consecutive
incubation at 90 nM was included, a second signal
level was reached (Fig. 7). This increase was much
higher than could be expected from a 1 : 1 binding
model. It indicated that more receptors became
accessible or available for STxB binding during the
second incubation step with a higher concentration.
The interaction of STxB–FITC and HT-29 cells
appeared to have faster kinetics than STxB–eGFP
also at 37 °C and 8 °C (Fig. 7). Moreover, data sug-
gest that the level of dissociation of the STxB con-
structs is lower at 8 °C comparing with higher
temperatures.
Analysis of STxB binding vs. internalization
To better understand the difference between the actual
interaction between STxB and cells and the internaliza-
tion of the toxin, the concentration dependency of the
interaction was studied in more detail. HT-29 cells
were incubated with a concentration series of STxB–
eGFP. By normalizing the data at 30 min (first part of
the 3 h association), it can be seen that the curve
shape is similar for the different concentrations for the
first half hour of incubation (Fig. 8A). At longer incu-
bation times, it seems that an equilibrium binding level
is reached within 1 h at a concentration of 3 nM. At
higher concentrations, the signal increases linearly in a
concentration-dependent fashion.
The internalization rate, relative to the amount of
bound STxB at different concentrations (Fig. 8B), was
estimated by relating the slope of the linear increase to
the amount of surface-bound STxB–eGFP at equilib-
rium at 3 nM. It was observed by a confocal micro-
scopy experiment that, when HT-29 cells are incubated
3 h with a final concentration of 90 nM, 40  2% of
the STxB–eGFP signal is at the intracellular environ-
ment (Fig. 8C). The intracellular rates obtained by the
RT-CBAs at the same concentration show that 18%
of the surface-bound STxB–eGFP is being internalized
per hour, which reflects that approximately 2–2.5 h
from the linear increase signal, 37% to 46% of the
STxBeGFP is in the intracellular environment. The
experiment shows that not only the amount of bound
STxB increases but also that internalization of STxB–
eGFP is promoted at higher concentrations, support-
ing a 2-step mechanism where binding is followed by
internalization.
Analysis of STxB clustering on cell surfaces
The internalization of STxB is a complex process
involving binding to Gb3 receptors, subsequent induc-
tion of cell membrane curvature and receptor cluster-
ing, and formation of tubular endocytic pits [7]. To
better understand the data in Fig. 8 and explore if the
increased concentration affects clustering of STxB
upon binding to Gb3, experiments exploring the effects
of adding more STxB on already bound labeled STxB
were performed with cells. For the experiments,
Fig. 5. Live imaging of Daudi cells
incubated with STxB–FITC (A–C) and
STxB–eGFP (D–F) for 3 h. (A) Transmitted
light imaging on Daudi cells. (B) FITC
fluorescence in the middle layer of the Z
scan. (C) Overlap of the fluorescence and
transmitted light images in A and B. (D)
Far-red dye staining on the plasma
membrane. (E) eGFP fluorescence in the
middle layer of the Z scan. (F) Overlap of
fluorescence images in D and E.
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unlabeled STxB and STxB labeled with a quencher
(STxB-ATTO540Q) were used.
Quenching assays were performed by allowing
STxB–FITC and STxB–eGFP to interact with Ramos
cells for 1 or 4 h, respectively (Fig. 9A,B). This was
followed by a subsequent addition of STxB-
ATTO540Q (black trace, shaded area). Two reference
experiments were performed. In the first experiment
with STxB–FITC, a similar addition was done with
unlabeled STxB (gray trace, shaded area; Fig. 9A)
while with STxB–eGFP, nothing was added (gray
trace, shaded area; Fig. 9B). The addition of STxB–
ATTO540Q resulted in an immediate slight decrease in
the fluorescent signal. Since the signal comes from
bound STxB–FITC and STxB–eGFP, it confirms that
the added STxB binds in proximity to the labeled
STxB. As the signal decrease can be a consequence of
physically displacing the fluorescent STxB constructs
or quenching of their fluorescence, a second reference
experiment was performed that consisted of the addi-
tion of unlabeled STxB to STxB–FITC. In this experi-
ment, no signal reduction was observed, suggesting
that there was no displacement of already bound
FITC-labeled STxB (gray trace, shaded area; Fig. 9A).
To further explore whether the decreased signal
upon addition of STxB-ATTO540Q was due to a dis-
placement of STxB–eGFP on the cells, an actual dis-
placement assay (without affecting the fluorescence
with a quencher) was performed with unlabeled STxB
and both Ramos and HT-29 cells (Fig. 9C,D). When
unlabeled STxB was added to cells preincubated with
STxB–eGFP, an unexpected increase in the signal was
Fig. 6. Kinetic studies of interactions between STxB–eGFP and cells at different temperatures. RT-CBA with Daudi (A–C) and HT-29 cells
(D–F) at 8 °C (A, D), room temperature (B, E) and 37 °C (C, F). Incubation for 3 h (black) and > 3 h (gray). The dotted line represented the
time point where dissociation was performed.
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observed (Fig. 9C,D). There was clearly no displace-
ment of already bound STxB–eGFP. Instead, by add-
ing unlabeled STxB, additional binding and/or
internalization of STxB–eGFP was promoted. This
could be related to the STxB binding induced cluster-
ing and subsequent internalization, which was more
effective at higher STxB concentrations.
Discussion
In this paper, a time-resolved method for studying
interactions with cells was used to show how Shiga
toxin subunit B (STxB) binds to and internalizes into
different cancer cell lines. In addition, by studying the
effects of temperature, concentration, and time, new
features of STxB function were revealed. STxB is of
great pharmaceutical interest because it can potentially
be exploited in the development of therapies with
higher tumor specificity, thus reducing side effects and
increasing efficacy. In the case of STxB, this could
offer new therapeutic strategies for colon cancer or
lymphoma. Internalizing toxins are considered to be
promising delivery tools, since such toxins have natu-
rally acquired specific characteristics through interac-
tion with their hosts. The nontoxic B-subunit of the
bacterial STxB, known for rapid binding and internal-
ization, has been exploited as a delivery tool for speci-
fic compounds in tumor imaging or therapy, thus
successfully demonstrating a useful functionality in
preclinical models [28].
Although STxB has been reported to be easily engi-
neered with functionality [29,30], the cellular mode of
Fig. 7. Kinetic studies of interactions between STxB variants and HT-29 cells at two concentrations and different temperatures. RT-CBA
experiments at 8 °C (A, D), room temperature (B, E) and 37 °C (C, F). STxB–FITC (A–C) and STxB–eGFP (D–F) were added in two
consecutive steps to final concentrations of 30 and 90 nM, followed by dissociation.
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action is complex, involving not only binding to the
receptor, but also receptor clustering, induction of
membrane curvature and endocytosis. Bioengineering
of STxB for specific applications, for example, involv-
ing conjugating or fusing it to specific peptides or
compounds, requires access to novel technologies for
evaluating and optimizing the efficacy and characteris-
tics of the mechanistic and kinetic details of binding
and uptake of new constructs. RT-CBA is a suitable,
but, yet, largely unexplored, technique as it can detect
fluorescent molecules or fluorescent proteins at the sur-
face and intracellular level over time, and thus provide
time-resolved information on how engineered STxB
constructs localize in living cells.
The present study demonstrated that RT-CBA is
indeed a very useful technique for studies of interac-
tions with living cells. It revealed that STxB has the
capacity to carry small molecules and small proteins
such as eGFP into cells. Indeed, STxB was able to
carry a molecule four times bigger than the monomer
(STxB is 7.7 kDa and eGFP is 32.7 kDa) to an intra-
cellular environment. There is an impressive capacity
for the STxB pentamer to carry 5 eGFP proteins (each
as STxB monomer fusion). As expected, the process
appeared to be slower for STxB–eGFP than for the
smaller STxB–FITC construct. A promising aspect is
the selective and rapid uptake of STxB by HT-29,
Ramos, and Daudi cells, which may reflect a high
capacity of STxB to penetrate tissue. The data thus
confirm that STxB demonstrates a high flexibility as a
scaffold for engineering of novel therapeutics. Further-
more, the new methods developed gave crucial infor-
mation about specific variables affecting the binding
and internalization of different STxB constructs.
To better interpret the complexities seen in the data,
we also need input from the field of cell membrane
biophysics which can help our understanding of mem-
brane mechanical processes caused by Shiga toxins.
Fig. 8. Analysis of STxB–eGFP HT-29 cell interaction and internalization. RT-CBA experiments with concentration series of STxB–eGFP from
3 to 270 nM, normalized at 30 min (A). Percentage of internalized STxB–eGFP per hour relative to the number of surface-bound STxB–eGFP
(B). The quantification of internalized STxB–eGFP, upon 3-h incubation with a final concentration of 90 nM, is represented as the intensity of
fluorescence normalized to the area between the membrane binding and internalization of STxB–eGFP (C). Results represented in bars are
expressed as the mean  SD (n = 3). eGFP fluorescence in the middle layer of the Z scan in living HT-29 cells (D).
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An interesting temperature dependency of the STxB
binding to living cells was observed. The STxB con-
structs dissociated less at 8 °C comparing with higher
temperatures. This temperature-dependent effect on
the binding of STxB was also observed in other studies
with the shiga and cholera toxin [20]. A possible expla-
nation could be due to the slower traffic of STxB [31],
as well the more stable tubular formation overtime,
which can lead to the STxB tubular entrapment [32].
On the other hand, when the interaction is evaluated
at temperatures representing normal biological systems
(37 °C), where metabolism, internalization, and degra-
dation of ligands takes place, all of these may con-
tribute to measurable effects. Under such conditions,
also de novo synthesis or recycling of the receptors can
change target availability, which can be reflected by
signals that are not necessarily proportional to the
number of ligand-target complexes on the cell surface.
When combining data from two consecutive injections
in the RT-CBA measurements, it is evident that the
binding dynamics of STxB with cellular receptors is
complex and cannot be characterized by a single 1-step
interaction with a 1 : 1 stoichiometry. This is clearly a
consequence of the far more complicated process of
binding and internalization of the toxin in a biological
evaluation context than a regular monovalent interac-
tion. In addition, it is strongly dependent on tempera-
ture, concentration, and time. The apparent affinity is
therefore not represented in a meaningful way by a
simple dissociation equilibrium constant (KD value), as
often presented in the literature [15,16,24].
The interesting complex interaction from STxB may
have several explanations of which one is the rapid
endosomal recycling of Gb3 receptors, induced by
Shiga toxin [31,33]. Some studies have shown that cre-
ating different STxB fusions do not change the capac-
ity of the protein to internalize by tubular pits [34,35].
The biphasic binding curves, with an initial fast bind-
ing event followed by a slow linear increase, were
observed. Since equilibrium binding was not reached,
it could possibly involve a receptor recycling mecha-
nism. The contribution of the two phases to the signal
and the observation of a pseudoequilibrium at the end
of the first phase were affected by the STxB concentra-
tion. Clearly, the more STxB bound to the cells (i.e.,
to the Gb3 receptors), the more efficient internaliza-
tion. Increasing the temperature also enhanced the
internalization process. A possible explanation might
Fig. 9. Analysis of STxB clustering on cell surfaces. RT-CBA experiments. (A, B) Quenching assays on Ramos cells incubated with 30 nM
STxB–FITC (A) and 90 nM STxB–eGFP (B) for 4 or 1 h, respectively. The shaded area represents a subsequent addition of 30 nM (A) or
270 nM (B) STxB–ATTO540Q (black trace, shaded area), 30 nM STxB (A, gray trace, shaded area) or nothing (B, gray trace, shaded area), the
dotted line represented the time point where the addition was performed. (C, D) Displacement assays with 30 nM STxB–eGFP and Ramos
cells (C) and 90 nM STxB–eGFP and HT29 cells (D) were incubated for 3 h. A subsequent addition of 90 nM (C) or 270 nM (D) of unlabeled
STxB was followed by a 3-h incubation. The dissociation was monitored afterward.
2417FEBS Letters 594 (2020) 2406–2420 ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies
J. C. Encarnac~ao et al. Real-time analysis of binding and internalization of STxB
be found in the mechanism of how STxB internalizes.
STxB is known to generate the formation of tubular
membrane invagination that guides the toxin into the
cell [22]. Therefore, the linear increase observed might
occur sooner with higher temperatures and high con-
centrations because STxB binds more rapidly and
quicker reaches levels required to form tubular mem-
brane. Hence, STxB cluster and tubular membrane
promote more STxB to bind through the recruitment
of receptors [21,36], as inferred from the linear increase
in signals and a high amount of STxB–eGFP and
STxB–FITC detected in the intracellular environment
after 3 h by confocal microscopy. The conventional
1 : 1 model based on a constant number of targets
over time is not accurate for such biological events in
living cells. Other models than the ‘one-to-one’ are
needed to estimate or compensate for all these biologi-
cal differences, and conventional affinity values (as-
suming one-to-one) may be directly misleading. This
means that there is plenty of evidence both from the
past and in this paper that justifies the interaction
deviating from the conventional 1 : 1 model.
Binding and internalization differences between cells
types can be explained by the three Gb3-binding sites
in each subunit B monomer, allowing for a tighter
binding to the target cell. However, the STxB binding
to cells might differ for different Gb3 species [28]. Pel-
lizzari et al. [37] showed that the affinity of Shiga tox-
ins is affected by the exact nature of the Gb3 fatty
acid. In fact, the tightest binding was observed for
mixtures of Gb3 species. It was shown that the fatty
acyl chain of Gb3 strongly affects the lateral organiza-
tion of STxB and impacts the overall membrane orga-
nization in phase-separated mixtures. The authors
concluded that the protein cluster formation depends
on the structure of the Gb3 fatty acid chains and area
demand of unsaturated fatty acids, which in combina-
tion affect membrane bending [7,17]. We have previ-
ously seen differences in binding of the same ligand to
the same target in various cells [37]. Moreover, the
proximity assay between STxB labeled with fluorescent
and quencher dyes also suggests that STxB proteins
bind close to each other and accumulate in membrane
clusters, increasing membrane tension and internaliza-
tion.
Another interesting fact was the displacement stud-
ies of STxB–eGFP with unlabeled STxB. It was possi-
ble to observe that when unlabeled STxB was added in
the presence of STxB–eGFP, a significant signal
increase was observed. This can be explained by the
equilibrium disturbance, where additional free ligands
disturb the equilibrium state and promote more ligand
binding to the free target, until eventually finding a
new equilibrium state. As seen in Fig. 8, the equilib-
rium state at higher concentrations is apparently a
state in which the relative internalization is more effi-
cient. It was also possible to observe signs of tubular
formations, that are characteristic for STxB, for
STxB–eGFP with confocal microscopy. In addition,
the amino coupling of the STxB with the fluorophore
FITC still did not affect the internalization of the pro-
tein. An interesting side effect of nonlabeled STxB
enhancing the function of labeled STxB is that the
production of new conjugate STxB proteins might not
need to produce perfectly pure conjugates, since nonla-
beled moieties only potentiate the function. Consider-
ing the rapid internalization of the STxB constructs, it
should be feasible to explore additional constructs to
deliver different molecules or to target organelles at an
intracellular level. In this case, measuring these kinds
of interactions on living cells turned out to be crucial
to characterize the possible new constructs with ade-
quate data that can aid optimization and decision
making.
In this study, we have shown that STxB has an
impressive capacity to deliver cargo to the intracellular
domain. The mechanism of action is complex, where
the binding kinetics of STxB to cell membranes have
been underestimated in different studies by not allow-
ing enough time to detect secondary events, specially
at lower temperatures. With better tools for characteri-
zation of the STxB internalization mechanisms, such
as the RT-CBA approach discussed in this report, the
full potential of the STxB capacity to deliver therapeu-
tic agents to specific cells can be better understood,
putatively leading to treatment modalities.
Acknowledgements
Microscopic imaging was performed with equipment
maintained by the BioVis Platform at Uppsala Univer-
sity. We thank to Dr Arie Geerlof and Dr Andre
Mour~ao (Institute of Structural Biology, Helmholtz
Zentrum M€unchen) for providing help on protein
expression and purification of the STxB constructs.
This project has received funding from the European
Union’s Framework Programme for Research and
Innovation Horizon 2020 (2014–2020) under the Marie
Sklodowska-Curie Grant Agreement No. 675555,
Accelerated Early staGe drug discovery (AEGIS).
Conflict of interest
Ridgeview Instruments AB (RIAB) develops and sells
the device LigandTracer, which is described in the
manuscript. Jo~ao Encarnac~ao, Jos Buijs, Karl
2418 FEBS Letters 594 (2020) 2406–2420 ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies
Real-time analysis of binding and internalization of STxB J. C. Encarnac~ao et al.
Andersson, and Hanna Bj€orkelund are employed by
RIAB. Jos Buijs, Karl Andersson, and Hanna Bj€orke-
lund are shareholders of RIAB. RIAB acknowledges
the adherence to all FEBS letter policies on sharing
data and materials. All equipment described in the
report is commercially available, and no patents
restrict the use of the described assays. Valeria Napoli-
tano, Giulia Opassi, Helena Danielson, Grzegorz
Dubin, Grzegorz Popowicz, and Helene Munier-Leh-
mann declare that they have nothing to disclose.
Author contributions
JCE, VN, GO, JB, KA, and HB designed all the
experiments. JCE, VN, and GO performed all the
experiments. JCE, VN, and GO wrote the manuscript.
GMP designed the expression plasmids. GD, UHD,
and HM-L provided crucial input and review on
methodology. All authors discussed the results and
commented on the manuscript.
References
1 Bae YH and Park K (2011) Targeted drug delivery to
tumors: myths, reality and possibility. J Control Release
153, 198–205.
2 Yao S, Zhu Y and Chen L (2013) Advances in targeting
cell surface signalling molecules for immune
modulation. Nat Rev Drug Discov 12, 130–146.
3 Nasiri H, Valedkarimi Z, Aghebati-maleki L and Majidi
J (2018) Antibody-drug conjugates: promising and
efficient tools for targeted cancer therapy. J Cell Physiol
233, 6441–6457.
4 Garcia-Alonso S, Ocana A and Pandiella A (2018)
Resistance to antibody-drug conjugates. Cancer Res 78,
2159–2166.
5 Sandvig K, Torgersen ML, Engedal N, Skotland T and
Iversen T (2010) Protein toxins from plants and
bacteria: probes for intracellular transport and tools in
medicine. FEBS Lett 584, 2626–2634.
6 Distler U, Souady J, H€ulsewig M and Drmic-Hofman I
(2009) Shiga toxin receptor Gb3Cer/CD77: Tumor-
association and promising therapeutic target in pancreas
and colon cancer. PLoS ONE 4(8), e6813. http://dx.doi.
org/10.1371/journal.pone.0006813
7 Watkins EB, Majewski J, Chi EY, Gao H, Florent J
and Johannes L (2019) Shiga toxin induces lipid
compression: a mechanism for generating membrane
curvature. Nano Lett 19, 7365–7369.
8 Mckenzie JE, Raisley B, Zhou X, Naslavsky N,
Taguchi T and Sheff D (2012) Retromer guides STxB
and CD8-M6PR from early to recycling endosomes,
EHD1 guides STxB from recycling endosome to Golgi.
Traffic 13, 1140–1159.
9 Mckenzie JE (2009) The Recycling Endosome is
Required for Transport of Retrograde Toxins.
University of Iowa, Iowa City, IA.
10 Renard H, Garcia-castillo MD, Chambon V, Lamaze C
and Johannes L (2015) Shiga toxin stimulates clathrin-
independent endocytosis of the VAMP2, VAMP3 and
VAMP8 SNARE proteins. J Cell Sci 128, 2891–2902.
11 Batisse C, Dransart E, Brulle L, Bai S, Godefroy S and
Johannes L (2015) A new delivery system for auristatin
in STxB-drug conjugate therapy. Eur J Med Chem 95,
483–491.
12 Barta P, Bj€orkelund H and Andersson K (2011)
Circumventing the requirement of binding saturation
for receptor quantification using interaction kinetic
extrapolation. Nucl Med Biol 32, 3–7.
13 Geyer PE, Maak M, Nitsche U, Perl M, Novotny A,
Slotta-Huspenina J, Dransart E, Holtorf A, Johannes L
and Janssen K-P (2016) Gastric adenocarcinomas
express the glycosphingolipid Gb3/CD77: targeting of
gastric cancer cells with Shiga toxin B-subunit. Mol
Cancer Ther 15, 1008–1017.
14 Kostova V, Dransart E, Azoulay M, Brulle L, Bai S,
Florent J-C, Johannes L and Schmidt F (2015)
Targeted Shiga toxin-drug conjugates prepared via Cu-
free click chemistry. Bioorg Med Chem 23, 7150–7157.
15 Gallegos KM, Conrady DG, Karve SS, Gunasekera
TS, Herr AB and Weiss AA (2012) Shiga toxin binding
to glycolipids and glycans. PLoS One 7, e30368.
16 Nakajima H, Kiyokawa N, Katagiri YU, Taguchi T,
Suzuki T, Sekino T, Mimori K, Ebata T, Saito M,
Nakao H et al. (2001) Kinetic analysis of binding
between Shiga toxin and receptor glycolipid Gb3Cer by
surface plasmon resonance. J Biol Chem 276, 42915–
42922.
17 Sch€utte OM, Werz DB, Patalag LJ, Weber LMC, Ries
A, Ro W et al. (2015) 2-Hydroxy fatty acid
enantiomers of Gb3 impact Shiga toxin binding and
membrane organization. Biophys Lett 108, 2775–2778.
18 Haller B, Staufer O, Dreher Y, Mersdorf U, Platzman I
and Spatz JP (2019) One-pot assembly of complex giant
unilamellar vesicle-based synthetic cells. ACS Synth Biol
8, 937–947.
19 Falguie T, Baron C, Hanau D, Lingwood C, Goud B,
Salamero J and Johannes L (2001) Targeting of Shiga
toxin B-subunit to retrograde transport route in
association with detergent-resistant membranes. Mol
Biol Cell 12, 2453–2468.
20 Fuchs G, Mobassaleh M, Donohue-Rolfe A,
Montgomery RK, Grand RJ and Keusch GT (1986)
Pathogenesis of shigella diarrhea: rabbit intestinal cell
microvillus membrane binding site for shigella toxin.
Infect Immun 53, 372–377.
21 Aigal S, Claudinon J and R€omer W (2015) Plasma
membrane reorganization: a glycolipid gateway for
microbes. Biochim Biophys Acta 1853, 858–871.
2419FEBS Letters 594 (2020) 2406–2420 ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies
J. C. Encarnac~ao et al. Real-time analysis of binding and internalization of STxB
22 Berland L, Gaus K, Windschiegl B, Aly MRE, Fraisier
V, Florent J et al. (2007) Shiga toxin induces tubular
membrane invaginations for its uptake into cells.
Nature 450, 670–675.
23 Bj€orkelund H, Gedda L and Andersson K (2011)
Comparing the epidermal growth factor interaction with
four different cell lines: intriguing effects imply strong
dependency of cellular context. PLoS One 6, 1–7.
24 Poirier C, Van ED, Delord B, Johannes L and Roux D
(2008) Specific adsorption of functionalized colloids at
the surface of living cells: a quantitative kinetic analysis
of the receptor-mediated binding. Biochim Biophys Acta
1778, 2450–2457.
25 Stenberg J, Spiegelberg D, Karlsson H and Nestor M
(2014) Choice of labeling and cell line influences
interactions between the Fab fragment AbD15179
and its target antigen CD44v6. Nucl Med Biol 41,
140–147.
26 Bondza S, Foy E, Brooks J, Andersson K, Robinson J,
Richaletm P and Buijs J (2017) Real-time
characterization of antibody binding to receptors on
living immune cells. Front Immunol 8, 1–11.
27 Encarnac~ao JC, Barta P, Fornstedt T and Andersson K
(2017) Impact of assay temperature on antibody
binding characteristics in living cells: a case study.
Biomed Rep 7, 400–406.
28 Johannes L and R€omer W (2010) Shiga toxins – from
cell biology to biomedical applications. Nat Rev
Microbiol 8, 105–116.
29 Watanabe-takahashi M, Sato T, Dohi T, Noguchi N,
Kano F, Murata M, Hamabata T, Natori Y and
Nishikawa K (2010) An orally applicable Shiga toxin
neutralizer functions in the intestine to inhibit the
intracellular transport of the toxin. Infect Immun 78,
177–183.
30 McKenzie J, Johannes L, Taguchi T and Sheff D
(2009) Passage through the Golgi is necessary for Shiga
toxin B subunit to reach the endoplasmic reticulum.
FEBS J 276, 1581–1595.
31 Martınez-Alonso E, Ballesta J and Martınez-Menarguez
JA (2007) Low-temperature-induced Golgi tubules are
transient membranes enriched in molecules regulating
intra-Golgi transport. Traffic 8, 359–368.
32 M€uller SK, Wilhelm I, Schubert T, Zittlau K, Imberty A,
Madl J, Eierhoff T, Thuenauer R and R€omer W (2017)
Gb3-binding lectins as potential carriers for transcellular
drug delivery. Expert Opin Drug Deliv 14, 141–153.
33 Ryou J-H, Sohn Y-K, Hwang D-E, Park W-Y, Kim N,
Heo W-D, Kim M-Y and Kim H-S (2016) Engineering
of bacterial exotoxins for highly efficient and receptor-
specific intracellular delivery of diverse cargos.
Biotechnol Bioeng 113, 1639–1646.
34 Amessou M, Carrez D, Patin D, Sarr M, Grierson DS,
Croisy A, Tedesco AC, Maillard P and Johannes L
(2008) Retrograde delivery of photosensitizer (TPPp-O-
b-GluOH)3 selectively potentiates its photodynamic
activity. Bioconjug Chem 19, 532–538.
35 Schubert T and R€omer W (2015) How synthetic
membrane systems contribute to the understanding of
lipid-driven endocytosis. Biochim Biophys Acta 1853,
2992–3005.
36 Pellizzari A, Pang H and Lingwood CA (1992) Binding
of verocytotoxin 1 to its receptor is influenced by
differences in receptor fatty acid content. Biochemistry
31, 1363–1370.
37 Varasteh Z and Orlova A (2015) Comparing the
measured affinity of 111In-labeled ligands for cellular
receptors by monitoring gamma, beta, or X-ray
radiation with three different LigandTracer devices. J
Radioanal Nucl Chem 304, 823–828.
2420 FEBS Letters 594 (2020) 2406–2420 ª 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies
Real-time analysis of binding and internalization of STxB J. C. Encarnac~ao et al.
